glp 1 agonist new drug GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness TrimRX | GLP-1 vs GIP:

While we continue to see Novo Nordisk as a wide-moat firm, with strong intangible assets surrounding its cardiometabolic business, we think the high obesity drug demand and scarcity of supply have driven share prices above their intrinsic value

Wegovy (semaglutide 2.4mg) is an FDA-approved drug that has undergone FDA review for safety, effectiveness, and manufacturing quality

doi: 10.1007/s40290-020-00374-5 26 MonneyMJornayvazFRGarianiK

Pharmacokinetics and safety profiles of beinaglutide injection, a Recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial

Blood samples were collected via facial vein puncture at 0, 30, 60, and 120 min post-administration for plasma GLP-1 concentration analysis

JAMA Surg 158(10):10031011 Miras AD et al (2019) Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial